The conventional view of traumatic brain injury as a trigger for neurological decline may be only half the story. For older adults, the relationship between TBI and conditions like dementia, stroke, epilepsy, and Parkinson's disease appears to run in both directions — meaning neurological vulnerability may precede the injury itself, not just follow it. This reframing has direct implications for how clinicians screen and counsel aging patients at fall risk.

This retrospective cohort study examined over 13,800 U.S. veterans aged 55 and older who sustained acute TBI — verified through concurrent ICD coding, emergency department visits, and brain imaging — between 1999 and 2021. They were matched 3:1 against more than 41,000 non-TBI veterans of similar age, sex, and race/ethnicity, with a mean age of 77.8 years and a predominantly male cohort (96.5%). Critically, researchers tracked incidence of dementia, stroke, epilepsy, and Parkinson's disease both one year before and one year after the TBI event, excluding anyone with pre-existing diagnoses. Veterans with TBI showed elevated incidence rates for all four conditions even in the pre-injury window compared to the matched non-TBI group — a finding the non-TBI cohort was tracked over a two-year window to contextualize.

This bidirectionality is scientifically meaningful and underappreciated in clinical practice. Most existing literature, including landmark work from the PREVENT Dementia cohort and large Danish registry studies, has focused on post-TBI neurodegeneration. The idea that subclinical neurological disease increases fall and injury risk — and thus TBI likelihood — introduces a confounding dynamic that retrospective TBI research may have systematically underestimated. For clinicians, this suggests that a TBI in an older patient should prompt not just future monitoring but a look backward: was there a prodromal process already underway? The study's primary limitations include its near-exclusive male, veteran population limiting generalizability, and reliance on administrative ICD codes rather than clinical adjudication. Still, the scale and temporal design make this an analytically important contribution — more confirmatory of emerging theory than paradigm-shifting, but clinically actionable.